SFPG
CRBP icon

Stonebridge Financial Planning Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Stonebridge Financial Planning Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10
Closed – – 409
2021
Q2 		$0 Hold
10
– – ﹤0.01% 424
2021
Q1 		$1K Hold
10
– – ﹤0.01% 414
2020
Q4 		$0 Hold
10
– – ﹤0.01% 391
2020
Q3 		$0 Hold
10
– – ﹤0.01% 380
2020
Q2 		$2K Hold
10
– – ﹤0.01% 375
2020
Q1 		$2K Hold
10
– – ﹤0.01% 391
2019
Q4 		$2K Buy
+10
New +$1.48K ﹤0.01% 343

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Stonebridge Financial Planning Group's CRBP Position: Q3 2021 in Review

Stonebridge Financial Planning Group sold out of Corbus Pharmaceuticals (CRBP) in Q3 2021, closing a stake of 10 shares.

Stonebridge Financial Planning Group first reported a position in CRBP in Q4 2019 and held it in 7 quarters. The position peaked at $2K in Q2 2020. 85 funds tracked by Wall St. Rank hold CRBP as of Q3 2021.

  • Stonebridge Financial Planning Group reported no remaining Corbus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Stonebridge Financial Planning Group sold 10 Corbus Pharmaceuticals shares in Q3 2021.
  • Stonebridge Financial Planning Group first reported a position in Corbus Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Stonebridge Financial Planning Group's Corbus Pharmaceuticals position peaked at $2K in Q2 2020.
  • 85 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2021.

Based on Stonebridge Financial Planning Group's 13F filing for Q3 2021, filed 8 Nov 2021.